Companies illegally selling unapproved Eli Lilly weight loss drug Retatrutide online
Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lilly, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found. CBS News investigative reporter and producer Daniel Gilbert has the story.
READ NEXT
More on the wire
FROM THE PUBLISHER
Political analyst Brit Hume on Wednesday evening said rising inflation and higher costs of living are hurting the Trump administration ahead of the midterms, as the Republican Party fights to maintain control in Congress. “This business with prices is just killing the administration,” Hume said on Fox News's “Special Report with Bret Baier.” He referenced...
FROM THE PUBLISHER
Canada could become a pivotal economy connecting North America, Europe and Asia.
FROM THE PUBLISHER
Today, I’m talking with Mustafa Suleyman, the CEO of Microsoft AI. As you’re no doubt aware, the biggest story in tech right now is the spiraling debate about AI safety and regulation. It should come as no surprise that Mustafa has strong opinions on how AI should be built and regulated. Microsoft just published a […]